medigraphic.com
ISSN 0035-0052 (Print)

2006, Number 2

<< Back Next >>

Rev Mex Pediatr 2006; 73 (2)

The neonate of mother with preeclampsia-eclampsia

Gómez-Gómez M, Danglot-Banck C

Language: Spanish
References: 19
Page: 82-88
PDF size: 83.89 Kb.


ABSTRACT

It is considered fetopathy by preeclampsia-eclampsia (FPE) to the group of alterations that presents the newborn from a mother with preeclampsia-eclampsia. These alterations can rebound on the growth, development and homeostasis of the product in the fetal life, during the childbirth work, in the neonatal period and to long term. Another factor that can be significant is the effect of the multiple medications administered to the mother. The preeclampsia-eclampsia at world level is observed in 5-9% of the pregnancies and is five to six times more frequent in the first pregnancy; is observed in 14-20% of the multiple gestations; in 30% of the women with uterine anomalies; in 25% of the patients with hypertension or chronic renal failure. Regarding eclampsia it happens a case in each 2,000 pregnant. It is also commented that in the woman with repetition of preeclampsia-eclampsia a recessive gene probably exists. The different complications that mother’s son can present are analyzed in the prenatal stage (intrauterine growth retardation, fetal death, hypoxia), to the moment of the childbirth (asphyxia, death), in the immediate neonatal (born prematurely, respiratory distress syndrome, meconium aspiration syndrome, acute hypoxic encephalopathy, peri-intraventricular hemorrhage) and long term (neurological sequels). Finally the current medical management is commented.


REFERENCES

  1. Norma técnico médica para la prevención y manejo de la preeclampsia-eclampsia. México: Dirección de Prestaciones Médicas, Instituto Mexicano del Seguro Social; 1995.

  2. Zhang J, Zeisler J, Hatch MC, Berkowitz G. Epidemiology of pregnancy-induced hypertension. Epidemiol Rev 1997; 19: 218-32.

  3. Roberts JM. Classification of hypertensive disorders of pregnancy. Lancet 1989; 2: 112.

  4. Davey DA, MacGuillivray I. The classification and definition of hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988; 158: 892-8.

  5. Gómez-Gómez M, Danglot-Banck C. El hijo de madre toxémica (fetopatía toxémica). En: Briones-Garduño JC, Díaz de León-Ponce M, editores. Preeclampsia-eclampsia. Diagnóstico, tratamiento y complicaciones. México: Distribuidora y Editora Mexicana; 2000: 63-77.

  6. López LMM. La toxemia del embarazo. Lecciones básicas. 2ª ed. México: Editorial Limusa; 1990.

  7. Saftlas AF, Olson DR, Frank AL. Epidemiology of preeclampsia and eclampsia in the United States 1979-1986. Am J Obstet Gynecol 1999; 163: 460-5.

  8. Douglas KA, Redman CW. Eclampsia in the United Kingdom. BMJ 1994; 309: 1395-400.

  9. Lindberg BS. Epidemiology of hypertension during pregnancy. Int J Technol Asses Health Care 1992; 8 (Suppl 1): 57-62.

  10. Lopez-Llera M. Main clinical types and subtypes of eclampsia. Am J Obstet Gynecol 1992; 166: 4-9.

  11. Gómez-Gómez M, Cruz-Bolaños JA, Jiménez-Balderas EA, Tudón-Garcés H. Recién nacido hijo de madre toxémica (fetopatía toxémica). Bol Med Hosp Infant Mex 1985; 42: 179-87.

  12. Gómez-Gómez M. Fetopatía toxémica. En: Gómez-Gómez M, editor. Temas selectos sobre el RN prematuro. México: Distribuidora y Editora Mexicana; 1996: 104-9.

  13. Sánchez-García L, Santos-Vera I. Informe estadístico anual del Departamento de Pediatría, Hospital de Gineco-Obstetricia # 3, Centro Médico “La Raza”. México: Instituto Mexicano del Seguro Social; 2006.

  14. Zuspan FP. Hypertensive disorders of pregnancy. In: Fanaroff AA, Martin RJ, editores. Neonatal-perinatal medicine. Disorders of the fetus and infant. 5a. ed. St. Louis: Mosby-Year Book Inc; 1992:186-98.

  15. Clifford SH. Posmaturity with placental dysfunctions: clinical syndrome and pathological findings. J Pediatr 1954; 44: 1-13.

  16. Gómez-Gómez M, Danglot-Banck C. Fetopatía toxémica. En: Gómez-Gómez M, Danglot-Banck C, editores. Temas de actualidad sobre el recién nacido. México: Distribuidora y Editora Mexicana; 1997: 61-74.

  17. Sibai BM, Caritis SN, Thom E. Prevention of preeclampsia with low-dose aspirin in healthy nulliparous pregnant women. NEJM 1993; 329: 1213-8.

  18. Carroli G, Duley L, Belizan JM. Calcium supplementation during pregnancy: a systematic review of randomized controlled trials. Br J Obstet Gynecol 1994; 101: 753-8.

  19. Gómez-Gómez M, Danglot-Banck C, García-de la Torre GS, Antonio-Ocampo A, Fajardo-Gutiérrez A, Sánchez-García ML, Ahumada-Ramírez E. Factores de riesgo de mortalidad en el hijo de madre toxémica. Gac Med Mex 2004; 140: 33-45.




2020     |     www.medigraphic.com